Comparison of Vaginal Gel and Intramuscular Progesterone for In vitro Fertilization and Embryo Transfer with Gonadotropin-Releasing Hormone Antagonist Protocol
- Author:
- No author available
- Journal Title:
- Chinese Medical Journal
- Issue:
- 13
- DOI:
- 10.4103/0366-6999.235106
- Key Word:
- Gonadotropin-Releasing Hormone Antagonist;Intramuscular Progesterone;Undergoing In vitro Fertilization and Embryo Transfer;Vaginal Progesterone
Abstract： Background:Luteal support is a key to patients undergoing in vitro fertilization and embryo transfer (IVF-ET) with gonadotropin-releasing hormone (GnRH)-antagonist protocol.This study aimed to compare the effect between vaginal progesterone (VP) and intramuscular progesterone (IMP) with GnRH-antagonist protocol after IVF-ET.Methods:A total of 1760 patients (18 years ≤ age ≤35 years) undergoing IVF-ET with GnRH-antagonist protocol were studied retrospectively between September 2014 and August 2015 in Peking University Third Hospital.In the patients,1341 patients received VP (VP group) and 419 patients received IMP (IMP group) as luteal support.We compared clinical outcomes between these two groups.The primary objective of the study was the live birth rate.Measurement data between the two groups were conducted using independent samples t-test.The variables in line with non-normal distribution were expressed as median (p25 and p75) and were compared using nonparametric Mann-Whitney U-test.Results:Live birth rate in VP group was 38.55％,significantly higher than that in the IMP group,which was 30.79％ (x2 =8.287,P =0.004).The clinical intrauterine pregnancy rate and implantation rate in VP group were also significantly higher than those in the IMP group (clinical intrauterine pregnancy rate 47.35％ vs.41.29％,x2 =4.727,P =0.030;implantation rate 30.99％ vs.25.26％,x2 =14.546,P ＜ 0.001).Any statistically significant differences in ectopic pregnancy and abortion rates between two groups were not observed.Conclusion:Luteal support with VP had better clinical outcomes for young women undergoing IVF-ET with GnRH-antagonist protocol.
- [1]A, Pellicer,C, Simón,J, Remohí.Effects of aging on the female reproductive system.[J].1995,10 Suppl 2.
- [2]Stocco C,Gibori G,Telleria C.The molecular control of corpus luteum formation, function, and regression.[J].2007,28(1).
- [3]Burger,N.Z.,Vaughn,T.C.,Silverberg,K.M.,etc.Vaginal (Crinone 8%) gel vs. intramuscular progesterone in oil for luteal phase support in in vitro fertilization: A large prospective trial[J].2012,97(2).
- [4]Michelle, van der Linden,Karen, Buckingham,Cindy, Farquhar,etc.Luteal phase support for assisted reproduction cycles.[J].2015,7.
- [5]J M, Ayoubi,R, Fanchin,D, Kaddouz,etc.Uterorelaxing effects of vaginal progesterone: comparison of two methodologies for assessing uterine contraction frequency on ultrasound scans.[J].2001,76(4).
- [6]A, Lightman,S, Kol,J, Itskovitz-Eldor.A prospective randomized study comparing intramuscular with intravaginal natural progesterone in programmed thaw cycles.[J].1999,14.
- [7]E, Cicinelli,L M, Schonauer,P, Galantino,etc.Mechanisms of uterine specificity of vaginal progesterone.[J].2000,15.
- [8]Yanushpolsky, Elena H..Luteal Phase Support in In Vitro Fertilization[J].2015,33(2).
- [9]R, Fanchin,C, Righini,D, de Ziegler,etc.Effects of vaginal progesterone administration on uterine contractility at the time of embryo transfer.[J].2001,75(6).
- [10]A C, Van Steirteghem,J, Smitz,M, Camus,etc.The luteal phase after in-vitro fertilization and related procedures.[J].1988,3.
- [11]Michelle, van der Linden,Karen, Buckingham,Cindy, Farquhar,etc.Luteal phase support for assisted reproduction cycles.[J].2011,(10).
- [12]E R, Norwitz,D J, Schust,S J, Fisher.Implantation and the survival of early pregnancy.[J].2001,345(19).
- [13]R, Fanchin,C, Righini,F, Olivennes,etc.Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization.[J].1998,13.
- [14]Karagozoglu SH,Karlikaya G,Kahraman S.The efficiency of progesterone vaginal gel versus intramuscular progesterone for luteal phase supplementation in gonadotropin-releasing hormone antagonist cycles: a prospective clinical trial.[J].2010,94(2).
- [15]Wennberg, Anna Lena,Opdahl, Signe,Bergh, Christina,etc.Effect of maternal age on maternal and neonatal outcomes after assisted reproductive technology[J].2016,106(5).
- [16]Hurwitz S,Greenberg L,Hornstein M,etc.Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study.[J].2010,94(7).
- [17]R A, Miles,R J, Paulson,R A, Lobo,etc.Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study.[J].1994,62.
- [18]Luciano G, Nardo,Hassan N, Sallam.Progesterone supplementation to prevent recurrent miscarriage and to reduce implantation failure in assisted reproduction cycles.[J].2006,13(1).